What RIC Group does

RIC Group is a privately-owned Belgian analytical services company headquartered in Kortrijk, Belgium, with an additional operational entity (SAS RIC) in Saint-Priest, France. Founded in 1986, the firm operates as a center of excellence providing analytical testing, instrumentation, and research services to pharmaceutical, biotechnology, chemical, food, and environmental industry clients across Europe. It is structured around four wholly-owned sub-brands: RIC technologies (analytical equipment and instrumental solutions), RIC resolve (chromatographic services), RIC biologics (analytical services for biological products and chemical entities in pharma and biotech), and RIC omics (biomarker discovery and drug target identification through omics technologies).

The company generates revenue through two primary streams: fee-for-service analytical testing and laboratory services (across chromatography, biologics, and omics disciplines) and the sale of analytical equipment through its RIC technologies subsidiary. Pricing is quote-based and not publicly disclosed, with services delivered via direct enterprise sales engagement. The group employs between 11 and 50 staff across its two legal entities (BV RIC in Belgium, SAS RIC in France) and markets itself primarily through its corporate website, LinkedIn presence, and direct client relationships. Its go-to-market is sales-led and consultative, leveraging 35+ years of accumulated scientific expertise to serve regulated, technical buyers in life sciences and adjacent sectors.

RIC Group is independently owned with no disclosed external investors, parent company, or institutional backing. There is no evidence of mergers, acquisitions, partnerships, funding rounds, or major leadership changes in the available data. The company maintains an active careers portal and an updated web presence (content dated 2025), indicating ongoing operations. No AI/ML capabilities, patents, regulatory actions, or named customer relationships are disclosed in the source material.

Name

RIC Group

Legal name

BV RIC

Website

https://ric-group.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

11–50 employees

Short description

RIC Group is a privately-owned Belgian analytical services firm operating across Belgium and France via four subsidiaries, providing chromatography, biologics characterization, omics research, and analytical instrumentation to pharmaceutical, biotech, chemical, food, and environmental clients in Europe.

Ownership category

akta.pro rank

Headquarters

HQ city

Kortrijk

HQ country

Belgium

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Analytical Testing Services: Fee-for-service analytical testing and laboratory services across chromatography, biologics, and omics disciplines for pharmaceutical, biotech, chemical, food, and environmental sectors
2. Instrumentation and Equipment Sales: Sale of analytical equipment and instrumental solutions through RIC technologies subsidiary

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

RIC Group is a privately-owned European center of excellence providing analytical solutions across pharmaceutical, biotech, chemical, food, and environmental industries. The company delivers fee-for-service analytical testing, chromatographic services, biologics characterization, omics-based biomarker and drug target discovery, and analytical equipment supply through four wholly-owned subsidiaries: RIC technologies, RIC resolve, RIC biologics, and RIC omics.

Product overview

RIC Group operates as a unified portfolio of four specialized analytical service brands serving the pharmaceutical, biotechnological, chemical, food, environment, and toxicology industries. The portfolio consists of RIC technologies (analytical equipment and instrumental solutions), RIC resolve (chromatographic services), RIC biologics (pharma and biotech analytical services), and RIC omics (omics-based biological research). Together, they provide comprehensive scientific know-how and technical expertise spanning equipment, services, and research capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• RIC technologies

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves3 records

Expansion highlights4 records

Broad incumbents

• Intertek: Global TIC (testing, inspection, certification) provider with significant pharma, food, and chemicals analytical services. Comparable to RIC Group as a multi-vertical testing services incumbent, though with global scale and broader scope.
• SGS: World's largest testing, inspection, and certification company with extensive pharma and life sciences analytical service offerings. Comparable as a broad incumbent in analytical testing across multiple industries including pharma, food, and environment.
• Labcorp Drug Development (formerly Covance): Major CRO offering central laboratory, bioanalytical, and biologics services. Comparable as an incumbent provider of analytical services to pharma/biotech, with global reach across drug development stages.
• WuXi AppTec: Large global CRO/CDMO with extensive analytical, biologics, and omics capabilities serving pharma and biotech. Comparable as a full-service analytical partner to pharma/biotech, though at significantly larger scale and broader scope.
• ICON plc: Global CRO providing clinical and laboratory services including bioanalytical and biomarker testing. Comparable as a broad analytical services provider to pharma/biotech, though primarily focused on clinical-stage support.

Direct peers

• Eurofins Scientific: Global leader in bioanalytical, pharmaceutical, food, and environmental testing services. Comparable to RIC Group as a multi-vertical analytical testing platform serving pharma/biotech, food, and environmental clients, though at vastly larger scale.
• Pharmaron: Global CRO offering laboratory services including analytical chemistry, biologics, and in vivo pharmacology to pharma/biotech. Comparable in scope of analytical services to pharma and biotech clients, including biologics and small molecules.
• Charles River Laboratories: Major CRO providing biologics characterization, biosafety, and analytical services to pharma and biotech. Directly comparable to RIC biologics' pharma/biotech analytical offering, particularly for biologics and complex modalities.

Emerging players

• Bio-Techne: Life sciences tools and reagents company with growing analytical services and omics capabilities. Comparable to RIC omics in biomarker discovery and omics-based research serving pharma/biotech research customers.

Regional players

• TÜV SÜD: European-based testing, inspection, and certification company with pharmaceutical, food, and chemical analytical offerings. Comparable as a European TIC player with multi-vertical analytical services, though more focused on certification than discovery-stage analytics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/ric-group
• Xx.com/ricbelgium

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RIC Group